Reveal

Bremelanotide, commonly known by the brand name Vyleesi, is a relatively novel medication that has garnered attention for its potential treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. This condition is characterized by a persistent or recurrent lack of sexual desire that causes marked distress or interpersonal difficulty. Bremelanotide works by acting asSeguir leyendo